BOSTON, Oct. 6, 2011 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) announced today that the Company is proud to support the National Breast Cancer Foundation (NBCF) by donating 5% of its sales from the MammoView® Breast Endoscopy Instrument line for the month of October to the NBCF. Solos currently sells instruments from its MammoView® line to hospitals across the Country through direct sales channels and social media.
MammoView® Instrument line contains 13 different Breast Endoscopy Components which are all featured on the Company's website http://www.solosendoscopy.com/newproductline.html.
The Solos MammoView® Breast Endoscopy System employs advanced microendoscopes and optical technology to give physicians sharp, clear images of the milk ducts, where the majority of the breast cancers arise. Solos' intraductal devices are designed to provide direct observation with any endoscopic video system while providing unprecedented image quality, using advanced minimally invasive technologies and tissue preservation techniques.
The National Breast Cancer Foundation (NBCF) is committed to spreading knowledge and fostering hope in the fight against breast cancer. By funding free mammograms for women who could otherwise not afford them and supporting research programs in leading facilities across the country, NBCF helps inspire the courage needed to win this monumental battle. The National Breast Cancer Foundation mission is to save lives through early detection and to provide mammograms for those in need. Their mission includes increasing awareness through education, providing diagnostic breast care services for those in need, and providing nurturing support services.
The MammoView® instrument line, designed exclusively for breast endoscopy, has become crucial to early breast cancer screening as a method to significantly red